Security key
69353Y103
PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP)
CUSIP: 69353Y103
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.00001 par value per share
- Shares outstanding
- 53,625,367
- Total 13F shares
- 40,492,185
- Share change
- -2,251,786
- Total reported value
- $65,594,864
- Put/Call ratio
- 25%
- Price per share
- $1.62
- Number of holders
- 91
- Value change
- -$3,771,661
- Number of buys
- 44
- Number of sells
- 55
Report period
Q2 2024
Institutions
91
Top holders
10
PMVP full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
PMV Pharmaceuticals, Inc. SEC filings
PMV Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 69353Y103
Recent filing periods:
Ownership snapshot
Top shareholders of PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
Lead holder
ORBIMED ADVISORS LLC
13D/G signal
—
Evidence rows
50
Latest as of
31 Mar 2024
13F
3/4/5
Lead comparable stake: 12%
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
12%
|
$11,007,995
6,475,291 shares
|
— | 31 Mar 2024 |
| ArrowMark Colorado Holdings LLC |
13F
Company
|
6%
|
$5,437,885
3,198,756 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
5.8%
|
$5,287,525
3,110,309 shares
|
— | 31 Mar 2024 |
| Euclidean Capital LLC |
13F
3/4/5
Company · 10%+ Owner
|
4.9%
|
$4,466,993
2,627,643 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
4.6%
|
$4,168,589
2,452,111 shares
|
— | 31 Mar 2024 |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
Company
|
4.4%
|
$3,987,113
2,345,361 shares
|
— | 31 Mar 2024 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
3.9%
|
$3,533,000
2,080,194 shares
|
— | 31 Mar 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
2.9%
|
$2,686,935
1,580,550 shares
|
— | 31 Mar 2024 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
2.6%
|
$2,325,455
1,367,915 shares
|
— | 31 Mar 2024 |
| BML Capital Management, LLC |
13F
Company
|
2.4%
|
$2,221,033
1,306,490 shares
|
— | 31 Mar 2024 |
| PFM Health Sciences, LP |
13F
Company
|
2.4%
|
$2,168,285
1,275,462 shares
|
— | 31 Mar 2024 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
2%
|
$1,861,925
1,095,250 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.7%
|
$1,535,498
903,137 shares
|
— | 31 Mar 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
Company
|
1.5%
|
$1,405,397
826,704 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
1.5%
|
$1,336,183
785,990 shares
|
— | 31 Mar 2024 |
| D. E. Shaw & Co., Inc. |
13F
Company
|
1.3%
|
$1,225,079
720,635 shares
|
— | 31 Mar 2024 |
| Ghost Tree Capital, LLC |
13F
Company
|
1.3%
|
$1,147,500
675,000 shares
|
— | 31 Mar 2024 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
1.2%
|
$1,114,284
655,461 shares
|
— | 31 Mar 2024 |
| EcoR1 Capital, LLC |
13F
Company
|
1.1%
|
$963,694
566,879 shares
|
— | 31 Mar 2024 |
| PERSONAL CFO SOLUTIONS, LLC |
13F
Company
|
1%
|
$935,581
550,342 shares
|
— | 31 Mar 2024 |
| CITIGROUP INC |
13F
Company
|
0.97%
|
$888,629
522,723 shares
|
— | 31 Mar 2024 |
| BARCLAYS PLC |
13F
Company
|
0.92%
|
$839,036
493,550 shares
|
— | 31 Mar 2024 |
| Opaleye Management Inc. |
13F
Company
|
0.88%
|
$802,130
471,481 shares
|
— | 31 Mar 2024 |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
Company
|
0.81%
|
$737,550
433,853 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
0.79%
|
$717,109
421,828 shares
|
— | 31 Mar 2024 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
0.75%
|
$679,507
399,710 shares
|
— | 31 Mar 2024 |
| TWO SIGMA ADVISERS, LP |
13F
Company
|
0.68%
|
$621,180
365,400 shares
|
— | 31 Mar 2024 |
| Acuitas Investments, LLC |
13F
Company
|
0.66%
|
$598,188
351,875 shares
|
— | 31 Mar 2024 |
| NORTHERN TRUST CORP |
13F
Company
|
0.63%
|
$574,828
338,134 shares
|
— | 31 Mar 2024 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
0.6%
|
$547,441
322,024 shares
|
— | 31 Mar 2024 |
| DIMENSIONAL FUND ADVISORS LP |
13F
Company
|
0.51%
|
$463,861
272,859 shares
|
— | 31 Mar 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
Company
|
0.5%
|
$452,071
265,924 shares
|
— | 31 Mar 2024 |
| M&T BANK CORP |
13F
Company
|
0.48%
|
$439,711
258,484 shares
|
— | 31 Mar 2024 |
| Point72 Asset Management, L.P. |
13F
Company
|
0.38%
|
$349,954
205,855 shares
|
— | 31 Mar 2024 |
| Verition Fund Management LLC |
13F
Company
|
0.37%
|
$341,595
200,938 shares
|
— | 31 Mar 2024 |
| Shay Capital LLC |
13F
Company
|
0.37%
|
$335,203
197,178 shares
|
— | 31 Mar 2024 |
| XTX Topco Ltd |
13F
Company
|
0.36%
|
$331,510
195,006 shares
|
— | 31 Mar 2024 |
| Nuveen Asset Management, LLC |
13F
Company
|
0.29%
|
$260,031
152,959 shares
|
— | 31 Mar 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.28%
|
$259,065
152,391 shares
|
— | 31 Mar 2024 |
| Schonfeld Strategic Advisors LLC |
13F
Company
|
0.26%
|
$241,039
141,788 shares
|
— | 31 Mar 2024 |
| UBS Group AG |
13F
Company
|
0.25%
|
$227,161
133,624 shares
|
— | 31 Mar 2024 |
| MARSHALL WACE, LLP |
13F
Company
|
0.25%
|
$224,137
131,845 shares
|
— | 31 Mar 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
0.22%
|
$202,757
119,269 shares
|
— | 31 Mar 2024 |
| Bank of New York Mellon Corp |
13F
Company
|
0.22%
|
$199,072
117,101 shares
|
— | 31 Mar 2024 |
| AQR CAPITAL MANAGEMENT LLC |
13F
Company
|
0.21%
|
$195,458
114,975 shares
|
— | 31 Mar 2024 |
| Man Group plc |
13F
Company
|
0.21%
|
$194,534
114,432 shares
|
— | 31 Mar 2024 |
| FISHMAN JAY A LTD/MI |
13F
Company
|
0.15%
|
$136,000
80,000 shares
|
— | 31 Mar 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.14%
|
$127,500
75,000 shares
|
— | 31 Mar 2024 |
| Assenagon Asset Management S.A. |
13F
Company
|
0.13%
|
$120,384
70,814 shares
|
— | 31 Mar 2024 |
| Marquette Asset Management, LLC |
13F
Company
|
0.12%
|
$108,816
64,009 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
91
Shares
40,492,185
Rows loaded
91
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
96
Q2 2024 holders
91
Holder diff
-5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.